High Frequency of Cognitive and Behavioral Impairment in Amyotrophic Lateral Sclerosis Patients with SOD1 Pathogenic Variants

被引:1
|
作者
Calvo, Andrea [1 ,2 ]
Moglia, Cristina [1 ,2 ]
Canosa, Antonio [1 ,2 ,3 ]
Manera, Umberto [1 ,2 ]
Vasta, Rosario [1 ]
Grassano, Maurizio [1 ]
Daviddi, Margherita [1 ]
De Mattei, Filippo [1 ]
Matteoni, Enrico [1 ]
Gallone, Salvatore [2 ]
Brunetti, Maura [1 ]
Sbaiz, Luca [2 ]
Cabras, Sara [1 ]
Peotta, Laura [1 ]
Palumbo, Francesca [1 ]
Iazzolino, Barbara [1 ]
Mora, Gabriele [1 ]
Chio, Adriano [1 ,2 ,3 ,4 ]
机构
[1] Univ Torino, ALS Ctr, Rita Levi Montalcini Dept Neurosci, Turin, Italy
[2] Azienda Osped Univ Citta Salute & Sci Torino, Neurol 1, Turin, Italy
[3] CNR, Inst Cognit Sci & Technol, Rome, Italy
[4] Univ Torino, Rita Levi Montalcini Dept Neurosci, Via Cherasco 15, I-10126 Turin, Italy
基金
欧盟地平线“2020”;
关键词
REPEAT EXPANSION; ALS; PROFILE; RESERVE; C9ORF72; BRAIN;
D O I
10.1002/ana.26928
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: While the cognitive-behavioral characteristics of amyotrophic lateral sclerosis (ALS) patients carrying C9orf72 pathological repeat expansion have been extensively studied, our understanding of those carrying SOD1 variants is mostly based on case reports. The aim of this paper is to extensively explore the cognitive-behavioral characteristics of a cohort of ALS patients carrying pathogenetic variants of SOD1 gene, comparing them to patients without pathogenetic variants of 46 ALS-related genes (wild-type [WT]-ALS) and healthy controls. Methods: All ALS patients seen at the Turin ALS expert center in the 2009-2021 period who underwent both cognitive/behavioral and extensive genetic testing were eligible to be included in the study. Only patients with SOD1 pathogenetic variants (n = 28) (SOD1-ALS) and WT-ALS (n = 829) were enrolled in the study. A series of 129 controls was also included. Results: Among the 28 SOD1-ALS patients, 16 (57.1%) had normal cognitive function, 5 (17.9%) isolated cognitive impairment (ALSci) (17.9%), 6 (21.4%) isolated behavioral impairment (ALSbi), 1 (3.6%) cognitive and behavioral impairment (ALScbi), and no one ALS-FTD. SOD1-ALS performed worse than controls in all explored domains, in particular Social Cognition and Language domains. SOD1-ALS patients had similar scores in all tests compared to WT-ALS, except the Story-based Empathy Task (SET), where they performed worse. Interpretation: Cognitive-behavioral impairment is much more common in SOD1 patients than previously assumed. SOD1-ALS are characterized by a more frequent impairment of Social Cognition and, less markedly, of Language domains. These findings have relevant implication both in the clinical and in the research setting, also considering recently approved treatment for SOD1-ALS. ANN NEUROL 2024
引用
收藏
页码:150 / 158
页数:9
相关论文
共 50 条
  • [31] 2 NOVEL SOD1 MUTATIONS IN PATIENTS WITH FAMILIAL AMYOTROPHIC-LATERAL-SCLEROSIS
    DENG, HX
    TAINER, JA
    MITSUMOTO, H
    OHNISHI, A
    HE, XX
    HUNG, WY
    ZHAO, YL
    JUNEJA, T
    HENTATI, A
    SIDDIQUE, T
    HUMAN MOLECULAR GENETICS, 1995, 4 (06) : 1113 - 1116
  • [32] Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis
    Tan, Wenzhi
    Pasinelli, Piera
    Trotti, Davide
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (08): : 1295 - 1301
  • [33] Brain Metabolic Changes in Amyotrophic Lateral Sclerosis with SOD1 Mutations
    Canosa, Antonio
    Calvo, Andrea
    Moglia, Cristina
    Vasta, Rosario
    Palumbo, Francesca
    Solero, Luca
    Di Pede, Francesca
    Cabras, Sara
    Arena, Vincenzo
    Zocco, Grazia
    Casale, Federico
    Brunetti, Maura
    Sbaiz, Luca
    Gallone, Salvatore
    Grassano, Maurizio
    Manera, Umberto
    Pagani, Marco
    Chio, Adriano
    NEUROLOGY, 2022, 98 (18)
  • [34] Mutant SOD1 Instability: Implications for Toxicity in Amyotrophic Lateral Sclerosis
    Tiwari, Ashutosh
    Hayward, Lawrence J.
    NEURODEGENERATIVE DISEASES, 2005, 2 (3-4) : 115 - 127
  • [35] A novel SOD1 mutation in familial amyotrophic lateral sclerosis.
    Hung, WY
    Yang, Y
    Kaplan, JP
    Deng, G
    Deng, HX
    Siddique, N
    Eisen, A
    Siddique, T
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A410 - A410
  • [36] A novel SOD1 gene mutation in familial amyotrophic lateral sclerosis
    Murakami, T
    Nagano, I
    Shoji, M
    Abe, K
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S58 - S58
  • [37] What is the clinical significance of SOD1 mutations in amyotrophic lateral sclerosis?
    Orrell, Richard W.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (05): : 473 - 473
  • [38] SOD1 in Amyotrophic Lateral Sclerosis: "Ambivalent" Behavior Connected to the Disease
    Pansarasa, Orietta
    Bordoni, Matteo
    Diamanti, Luca
    Sproviero, Daisy
    Gagliardi, Stella
    Cereda, Cristina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [39] SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis
    Rouleau, GA
    Clark, AW
    Rooke, K
    Pramatarova, A
    Krizus, A
    Suchowersky, O
    Julien, JP
    Figlewicz, D
    ANNALS OF NEUROLOGY, 1996, 39 (01) : 128 - 131
  • [40] Structural and Functional Analysis of Human SOD1 in Amyotrophic Lateral Sclerosis
    Alves Moreira, Lorenna Giannini
    Pereira, Livia Costa
    Drummond, Priscila Ramalho
    De Mesquita, Joelma Freire
    PLOS ONE, 2013, 8 (12):